Sponsor:
Abramson Cancer Center at Penn Medicine
Code:
NCT06551116
Conditions
HER2-positive Metastatic Breast Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
CE-10-IVD
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-06-16. This information was provided to ClinicalTrials.gov by Abramson Cancer Center at Penn Medicine on 2025-05-15.